Gline Matthew

CEO, DirectorRoivant Sciences Ltd. (ROIV) · full profile →Form 4 · filed Apr 1, 2026
No Open-Market Flow
Open-Market Buys
$0
Open-Market Sells
$0
Net Open-Market Flow
$0
Transactions
4
3 non-derivative · 1 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Mar 31, 2026Tax withholding(F)305K$27.70$8.4M17.0M
Mar 30, 2026Option exercise(M)97K17.4M
Mar 30, 2026Tax withholding(F)54K$26.41$1.4M17.3M

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Mar 30, 2026Option exercise(M)2.2M$11.50$25.0M0

Transaction Codes

F
Shares withheld for taxes
M
Option exercise / conversion

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001635088-26-000034) within minutes of acceptance. Every field above traces to the original document. Verify it directly: